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Abstract - The human derma emits volatile compounds whose interaction with a 
receiver’s olfactory sensory system may affect individual recognition and mating 
preferences. Studies suggest that both genes and environmental factors determine 
characteristic odor of an individual. Here, we use solid phase micro-extraction and 
GC-MS to identify 3-methylbutanal (3-MB) in human axillary odor, show that the 
abundance of this volatile compound varies significantly between individuals and 
demonstrate in-vitro that its formation may be influenced by interaction between 
human leukocyte antigen peptide and dermal microflora. 
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INTRODUCTION 
Human odor comprises many volatile compounds whose origin(s) is still largely 
unexplained. Penn & Potts (1998) reviewed hypotheses suggesting a role for the 
genes which encode human leukocyte antigens (HLA) in the origin of these 
compounds. The HLA complex enables the immune system to recognise pathogens by 
capturing and presenting exogenous and endogenous antigen peptides to T-cells. 
HLA may also contribute to the development of a unique odor signature that 
influences mating preferences in humans (Penn & Potts, 1998). HLA is specifically 
distributed across human skin (Imayama et al., 1992) and its fragments are present in 
sweat (Zavazava et al., 1990), thus providing an opportunity for the skin microflora to 
be involved in odor formation (Leyden et al., 1981). Our in-vivo study was designed 
to detect chemosignals which may be used as discriminative markers of individuality. 
An in-vitro experiment was also carried out to test the HLA–microflora hypothesis 
(Penn and Potts, 1998). 
 
METHODS AND MATERIALS 
Sampling of axillary odor. Eighteen volunteers comprised 8 females and 10 males 
(age range 22-51). The headspace of the left underarm region of each volunteer was 
sampled on three consecutive occasions, spaced 7 d apart, by solid phase micro-
extraction (SPME). The SPME fiber selected was divinylbenzene-carboxen-
polydimethylsiloxane (Supelco, UK). The fiber was positioned within a perforated 
(ID, 4 mm) 15 ml glass vial (Sigma-Aldrich) by piercing a septum in a cap with the 
SPME needle; this sampling device is the subject of UK Patent Application No. 
0507950.4. To standardize environmental effects on odor profiles, the volunteers 
followed an established hygiene regime (Roberts et al., 2005). After 50 min of 
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axillary sampling at room temperature, the fiber was introduced into the GC for 
sample desorption. The air in the sampling room was monitored for background 
volatiles using the same absorbent material. 
 
Gas Chromatography-Mass Spectrometry analysis. GC-MS analysis of the odor 
compounds was performed using an Agilent 6890N GC. The GC injection port liner 
used was a SPME injection sleeve of 0.75 mm ID (Supelco). SPME desorption was at 
230 
o
C, in pulsed splitless mode for 2 min at 25 psi. The GC was coupled to a 5973 
mass selective detector (EI+, electron voltage 70 eV, full scan mode in a range of m/z 
35-400 amu, interface temperature of 300 
o
C) Chemstation (Agilent Technology, 
UK). Separation of compounds was performed on a Zebron, ZB-Wax (30m × 0.25mm 
× 0.25 µm) capillary column coated with 100% polyethylene glycol (Phenomenex, 
UK). The carrier gas used was helium at a flow rate of 1ml min
-1
. The oven 
temperature ramp program was 40 
o
C held for 5 min, then raised to 100 
o
C at 3 
o
C 
min
-1
 (5 min), followed by 5 
o
C min
-1
 to 150 
o
C (5 min) and reaching 230 
o
C at 5 
o
C 
min
-1
 (8 min). 
 
Culturing of axillary bacteria. A sterile swab, pre-treated in 0.8% NaCl, was applied 
for 10 sec to the left axilla to harvest its bacterial flora. The swab was transferred into 
20 ml of glucose-enriched media (glucose 1%, ammonium chloride 0.5%, sodium 
dihydrogen orthophosphate 0.2% with the final pH adjusted to 7.2) prepared in a 
screw cap bottle. The bottle was kept in an orbital shaker at 37 
o
C, 160 rpm, for 12 h. 
1 ml of the culture was then transferred into a sterile 2 ml Eppendorf centrifuge tube 
which was spun for 10 min at 11500g. The supernatant was removed and the pellet 
was washed 8 times with sterile distilled water. The pellet was then re-suspended in 
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the sterile distilled water and a total bacterial count was equated to McFarland 
turbidity standard 10 (6 x 10
7
cfu ml
-1
).  
 
Preparation of substrate solution. The LRGYYNQSED and GSHSMRYFST peptides 
were synthesized by Sigma Genosys Ltd, UK. To prepare a substrate solution, 1.5 mg 
of each 10 amino acid HLA peptide was dissolved in 1 ml filtered (0.25mm) sterile 
distilled water. 4.4 mg KH2PO4, 4.8 mg Na2HPO4, 1.0 mg NH4Cl, 0.5 mg 
MgSO47H2O were added to each substrate solution to make a final substrate solution. 
 
Headspace analysis of medium. 20 µl of the re-suspended pellet and 115 µl of the 
final substrate solution were added to a 2 ml GC-MS glass vial containing 2.5 µl of 
vitamin solution; made of 0.05% thiamine (aneurine) hydrochloride, 0.05% 
riboflavin, 0.05% niacin, 0.05% pyridine hydrochloride, 0.05% inositol, 0.05%, 
calcium pantothenate, 0.05% p-aminobenzoic acid and 0.025% biotin. The vial was 
capped and the mixture was incubated in an orbital shaker (160 rpm) at 37 
o
C for 48 
h. The cap septum was then pierced with the protective needle covering the SPME 
fiber and the fiber was extruded to sample the headspace over the medium. The 
sampling was carried out for 30 min over a heating block set at 50 
o
C. After sampling, 
the fiber was immediately introduced into the GC for sample desorption. In all cases a 
negative control of the headspace of the bacterial culture without added peptide was 
analyzed. Each sample was analyzed in duplicate. 
 
Data analysis. Ion 41 was selected as one of the main ions of 3-MB from the GC-MS 
profile of an individual and its abundance was read. Seven other compounds, across 
the same profile of the individual, containing ion 41 were also selected, their 
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abundances in the ion were read and the mean of their abundances was calculated. 
The abundance in the ion of 3-MB was divided by the mean to obtain a standardized 
value in ion 41 for 3-MB. The standardized value was calculated for every individual 
profile (Table 1). Comparisons of the abundance of 3-MB between individuals were 
performed using repeated-measures ANOVA; results at the <0.05 probability level 
were considered significant. 
 
RESULTS AND DISCUSSION 
The GC-MS analysis of the axillary odor of 18 volunteers revealed a number of 
compounds among which 3-MB was noted as a potential link to HLA (Montag et al., 
2001). The individual variability in abundance of 3-MB during three weeks of 
sampling is shown in Table 1. Since zero values do not represent a confirmed absence 
of the chemosignal, they were initially excluded from the analysis to test whether the 
variation in emission of 3-MB between the individuals was significant. ANOVA 
revealed significant variation in the signal between 13 subjects (F1,12=22.9, P < 
0.001), while variation across weeks was not significant (F2,24=1.9, P > 0.05). There 
were also significant disparities in the signal between all 18 subjects when zero values 
were included in the analysis (F1,17=40.125, P < 0.001; data were square-root 
transformed prior to analysis due to significant departures from normality), while, 
again, there was no significant variation in the signal across weeks (F2,34=3.07, P > 
0.05). These statistical analyses may indicate a possible genetic origin of 3-MB, 
especially after taking into account the previous observation (Montag et al., 2001) that 
strains of environmentally controlled congenic mice, differing only in the major 
histocompatibility complex (MHC or HLA in humans) expression, can be 
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distinguished on the basis of differences in the ratio of their urine volatile signals, 
including 3-MB. 
An in vitro experiment was carried out to determine whether 3-MB may be 
formed from the interaction between HLA peptides and dermal microflora. Two 10-
amino-acid peptides, whose sequences are expressed in the α1 domain of the HLA 
class 1 region (Mason, 1998), namely LRGYYNQSED and GSHSMRYFST, were 
synthesized. The first sequence was selected because leucine (L) neighbors arginine 
(R) and because it has previously been shown that their substitutions in congenic 
mutant mice, differing only in three amino acids in the MHC region (Schulze et al., 
1983), allowed olfactory distinction between the strains (Yamazaki et al., 1983). The 
other peptide was chosen for the lack of L and L-R linkage in its sequence. 
In the first instance, microflora cultured from individual ORE_2, whose 
axillary odor contained 3-MB in all 3 weekly samplings (Table 1), was incubated in 
two separate media; one contained the LRGYYNQSED peptide and the other the 
GSHSMRYFST peptide. The gaseous phase (headspace) above the surface of the 
medium, in each case, was sampled and analyzed for 3-MB. The compound was 
detected in the headspace over the LRGYYNQSED incubate (Figure 1A) but not for 
GSHSMRYFST (Figure 1B). If the cutaneous microbial population is affected by an 
individual’s genotype, and possibly phenotype, we would predict that the sampled 
microflora from individual ORE_5, who was not associated with a positive 3-MB 
signal (Table 1), would not yield the signal when incubated with LRGYYNQSED. 
The subsequent analysis did not detect 3-MB in the headspace of the medium (Figure 
1C). The results of the in vitro experiment were reproduced using the microflora 
cultured from ORE_8 and ORE_7. These findings are in agreement with the 
hypothesis that genes and microflora may influence formation of the odor (Penn & 
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Potts 1998), although it remains unclear whether the production of the chemosignal: i) 
is HLA-sequence specific, ii) depends on the L-R linkage, or iii) is entirely due to the 
encoded presence of leucine in the peptide. A further study on the substitutions of the 
amino-acids in the LRGYYNQSED may reveal the extent of HLA contribution to the 
production of the chemosignal. 
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TABLE 1. AXILLIARY ABUNDANCE OF ION 41 OF 3-METHYLBUTANAL IN 
18 HUMAN SUBJECTS SAMPLED OVER THREE WEEKS 
Subjects Week 1  Week 2  Week 3 
ORE_1 
ORE_2 
ORE_3 
ORE_4 
ORE_5 
ORE_6 
ORE_7 
ORE_8 
ORE_9 
ORE_10 
ORE_11 
ORE_12 
ORE_13 
ORE_14 
ORE_15 
ORE_16 
ORE_17 
ORE_18 
2.21 
1.6 
0.62 
0 
0 
0.1 
0 
0.33 
1.78 
0.4 
0.61 
0.14 
0.14 
0.62 
0 
0 
0.78 
0.15 
0.79 
2.13 
0.78 
0.64 
0 
0.07 
0 
0.05 
0.89 
0.34 
0.51 
0.28 
0.17 
1.69 
0 
0.57 
0.21 
0.13 
1.65 
1.05 
1.44 
1.74 
0 
0.29 
0 
0.04 
1.19 
1.21 
1.32 
0.28 
0.21 
2.3 
0 
0.31 
1.09 
0.21 
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2 5 0 0 0 0
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4 0 0 0 0 0
4 5 0 0 0 0
T im e -->
A b u n d a n c e
T I C :  S W 0 5 0 8 0 8 1 3 . D
 
B 
0 . 2 0 0 . 4 0 0 . 6 0 0 . 8 0 1 . 0 0 1 . 2 0 1 . 4 0 1 . 6 0 1 . 8 0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0
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C 
0 . 2 0 0 . 4 0 0 . 6 0 0 . 8 0 1 . 0 0 1 . 2 0 1 . 4 0 1 . 6 0 1 . 8 0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0
2 0 0 0 0 0
2 5 0 0 0 0
3 0 0 0 0 0
3 5 0 0 0 0
4 0 0 0 0 0
4 5 0 0 0 0
T im e -->
A b u n d a n c e
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FIG. 1. GC-MS profiles of the gaseous phase of the incubation media. (A) Medium 
containing microflora cultured from the individual consistently emitting 3-MB and 
LRGYYNQSED; 3-MB was detected at 1.75 minutes (arrowed); (B) as in (A) except 
that GSHSMRYFST peptide was used as the substrate; 3-MB was not detected; (C) 
the medium containing microflora cultured from the individual with undetectable 3-
MB and LRGYYNQSED; 3-MB was not detected. 
